ArticleLife (Basel, Switzerland)2022

A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT).

Noriko Tomita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.